retatrutide phase 2 type 2 diabetes trial 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Retatruitude Clinical Trial | TikTok

June 21, 2025

If a severely obese patient (BMI 35 to 39.9) with one or more health conditions, or a morbidly obese patient (BMI 40 or greater), has not reached 10% TBWL in six months, they should be referred for bariatric surgery

ALCAR maintains mitochondria in practically every cell in your body, but seems especially important in the brain, which consumes 20% of the bodys energy and generates a lot of toxic byproducts as a result

1 Like AgentSmith February 10, 2024, 2:43pm #14 I came across this thread searching for GLP-1 impacts on mTOR (a curiosity), and can describe my experience

I joined the program after seeing the amazing results my daughter had with the medication, and I thought, why not try it for myself